TNFRSF11B and type 2 diabetes mellitus: Given that OPG levels have been identified as a biomarker for bone turnover used to predict implant prognosis [9], the current research was directed to evaluate bone density and OPG levels in the PICF in lasered versus non-lasered controlled T2DM patients.